• No results found

The developed sustained release tablets have acceptable

FORMULATION AND EVALUATION OF SUSTAINED    RELEASE TABLETS OF VILDAGLIPTIN

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF VILDAGLIPTIN

... Key words: Vildagliptin, HPMC (K 100 LV, K100M, K15M & K4M), sustain release matrix tablets. INTRODUCTION Diabetes a global public health problem is a chronic disease and is now growing as an epidemic in ...

7

FORMULATION AND EVALUATION OF MIGLITOL SUSTAINED RELEASE TABLETS

FORMULATION AND EVALUATION OF MIGLITOL SUSTAINED RELEASE TABLETS

... these tablets were done in vitro dissolution studies from F1 to F7. The release profile of Miglitol sustained release tablets from different batches of formulated tablets were ...

5

Formulation and Evaluation of Nicardipine Sustained Release Tablets

Formulation and Evaluation of Nicardipine Sustained Release Tablets

... studies have to be carried out with the purpose of selecting right dosage form and a stable ...which have to be controlled in order to give reliable and reproducible quality product ...

5

Formulation and evaluation of magnesium sustained release tablets

Formulation and evaluation of magnesium sustained release tablets

... drug release rate from dosage form is controlled mainly by the type and proportion of polymer used in ...drug release from the inherent first order behaviour especially to achieve a constant rate of drug ...

6

Effect of different polymers on release of the sustained release tablets of the glipizide

Effect of different polymers on release of the sustained release tablets of the glipizide

... ABSTRACT Sustained release delivery systems have shown to be of better significance in release rate for ...on release of the sustained release tablets of the ...

8

Sustained release aceclofenac matrix tablets constituting Kollidon sustained release (KSR) (polyvinyl acetate and

Sustained release aceclofenac matrix tablets constituting Kollidon sustained release (KSR) (polyvinyl acetate and

... a sustained release aceclofenac matrix tablet with KSR. Sustained release tablets of aceclofenac using KSR have been successfully optimized to the drug release pattern ...

8

Formulation Development and Evaluation of Sustained Release Tablets of Aceclofenac

Formulation Development and Evaluation of Sustained Release Tablets of Aceclofenac

... And Sustained Release Concept 3,9-15 : Over the years, many terms (and abbreviations), such as sustained release(SR), sustained action (SA), prolonged action (PA), controlled ...

128

Formulation and Evaluation of Ondansetron Hydrochloride Sustained Release Tablets

Formulation and Evaluation of Ondansetron Hydrochloride Sustained Release Tablets

... controlled release systems The oral route is the most convenient and common mode for administration of controlled release ...systems have gained importance because of the technological advance made ...

113

Formulation and Evaluation of Tamsulosin Hydrochloride Sustained Release Tablets.

Formulation and Evaluation of Tamsulosin Hydrochloride Sustained Release Tablets.

... 400 have been used as the vehicle for parenteral dosage ...they have only limited binding action when used alone, and can prolong disintegration if present in concentrations greater than 5% ...

103

Development and Evaluation of Sustained Release Bilayer Tablets of Carvedilol.

Development and Evaluation of Sustained Release Bilayer Tablets of Carvedilol.

... 1.1 SUSTAINED RELEASE DOSAGE FORM: 1, 2 Sustained release dosage forms are designed to achieve a prolonged therapeutic effect by continuously releasing medication over extended period of after ...

113

Formulation Development of Metformin Hydrochloride Sustained Release Tablets

Formulation Development of Metformin Hydrochloride Sustained Release Tablets

... oral sustained release Metformin hydrochloride matrix tablets by using hydroxyl methyl cellulose polymer (HPMC) as rate controlling factor and to evaluate drug release parameters as per ...

137

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF PIOGLITAZONE

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF PIOGLITAZONE

... efforts have been made to develop floating drug delivery system for Pioglitazone hydrochloride containing Ethyl cellulose and Eudragit RS ...The tablets of all formulation were subjected to various ...

22

FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF VALSARTAN

FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF VALSARTAN

... RESULTS AND DISCUSSION In the Preformulation studies, Characteristic of drug compatibility studies were performed using FTIR spectrophotometer. The FTIR spectrum of pure drug and physical mixture of drug and polymer were ...

15

FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE TABLETS OF LORNOXICAM

FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE TABLETS OF LORNOXICAM

... rapid. Tablets are compressed of two or three tablets of granulation compressed ...They have the appearance of a sandwich because the edges of each tablet are ...Extended Release systems were ...

8

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MEFORMIN HYDROCHLORIDE

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MEFORMIN HYDROCHLORIDE

... Drug Release Kinetics -Model Fitting of the Dissolution Data Whenever a new solid dosage form is developed or produced, it is necessary to ensure that drug dissolution occurs in an appropriate ...

17

FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF LORATADINE

FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF LORATADINE

... controlled release drug delivery device, Bioadhesive gastrointestinal drug delivery system 7 ...Davis developed a method for overcoming the difficulty experienced by persons of gagging and choking while ...

11

DESIGN AND EVALUATION OF LAMOTRIGINE ORAL SUSTAINED RELEASE TABLETS

DESIGN AND EVALUATION OF LAMOTRIGINE ORAL SUSTAINED RELEASE TABLETS

... lamotrigine have been approved for marketing, for instance, conventional compressed instant release (IR) tablets comprising 25 mg, 50 mg, 100 mg, 150 mg or 200 mg of active ingredient 4 ...

6

DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE TABLETS OF RANOLAZINE

DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE TABLETS OF RANOLAZINE

... Available online on www.ijpsr.com 923 INTRODUCTION: Ranolazine was approved by the US FDA in January 2006 for the treatment of chronic stable angina in patients who have had an inadequate response to traditional ...

7

Formulation and Evaluation of Nitazoxanide  Sustained-Release Matrix ‎Tablets

Formulation and Evaluation of Nitazoxanide Sustained-Release Matrix ‎Tablets

... controlled release products in the pharmaceutical field are well known and include the ability of maintaining the desired blood level of a drug over a almost longer ...many sustained-release and ...

9

FORMULATION AND IN VITRO CHARACTERIZATION OF SUSTAINED RELEASE TABLETS OF PRIMIDONE

FORMULATION AND IN VITRO CHARACTERIZATION OF SUSTAINED RELEASE TABLETS OF PRIMIDONE

... basis. Sustained release (SR) preparations are not new but several new modifications are being ...“delayed release” when compared to “rapid” or “conventional” release ...“controlled ...

10

Show all 10000 documents...

Related subjects